ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Breast Cancer
Cancer
Colorectal Cancer
Uterine Cervical Cancer
Stomach Cancer

Endometrial Cancer trials near Kansas City, KS, USA:

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer (EndoMAP)

This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune check ...

Enrolling
Endometrial Cancer
Drug: Talazoparib
Drug: Atezolizumab - 21 Day Cycle

Phase 1, Phase 2

Alliance Foundation Trials

Westwood, Kansas, United States and 20 other locations

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Active, not recruiting
Endometrial Cancer
Drug: INCAGN02385
Drug: pemigatinib

Phase 2

Incyte
Incyte

Kansas City, Missouri, United States and 66 other locations

for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...

Active, not recruiting
Endometrial Cancer
Drug: Matching placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Kansas City, Missouri, United States and 77 other locations

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...

Active, not recruiting
Endometrial Cancer
Drug: Paclitaxel
Drug: Sacituzumab govitecan-hziy

Phase 3

Gilead Sciences
Gilead Sciences

Kansas City, Missouri, United States and 188 other locations

to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...

Enrolling
Endometrial Adenocarcinoma
Drug: ACR-368
Drug: Gemcitabine

Phase 2

Acrivon Therapeutics

Kansas City, Missouri, United States and 89 other locations

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...

Enrolling
Uterine Cancer
Hormone Receptor-positive/Her2 Negative Breast Cancer
Drug: Carboplatin
Drug: Pembrolizumab

Phase 1, Phase 2

Genmab
Genmab

Westwood, Kansas, United States and 66 other locations

global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gynecological cancers...

Enrolling
Endometrial Cancer
Peritoneal Neoplasms
Drug: Bevacizumab 10 mg/kg
Drug: Nab-paclitaxel 80 mg/m^2

Phase 2

Corcept Therapeutics
Corcept Therapeutics

Kansas City, Missouri, United States and 44 other locations

The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor...

Enrolling
Solid Tumor
Ovarian Neoplasms
Drug: NKT3964

Phase 1

NiKang Therapeutics

Fairway, Kansas, United States and 18 other locations

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: Capecitabine
Drug: Cisplatin

Phase 2

AstraZeneca
AstraZeneca

Kansas City, Kansas, United States and 93 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1

Exelixis
Exelixis

Kansas City, Missouri, United States and 123 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems